Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation
Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation
This study is prospective Cohort study which was performed in multicenter (General Hospital)
 in Korea. Inclusion criteria is patients with atrial fibrillation taking Elxaban (generic
 drug of apixaban) who visit hospital. The purpose is to analyze bleeding (major bleeding,
 minor bleeding), stroke, systemic embolism, death, other clinical events (acute myocardial
 infarction, pulmonary embolism, transient ischemic attack, hospitalization), drug adherence,
 questionnaire of life quality (AFEQT), cognitive function (KDSQ) according to the use of
 Elxaban.
Inclusion Criteria:

 1. patients with atrial fibrillation taking Elxaban (patients with age more than 19)

 2. Patients who agree with study inclusion

 Exclusion Criteria:

 1. patients who do not agree with study inclusion

 2. patients with age less than 19

 3. Pregnancy, Breastfeeding